<

The new version of Medicare Drugs is published

 
   February 23, the Ministry of Social Affairs announced the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drugs Catalog (2017 Edition)" (hereinafter referred to as "the new version of the drug directory") and issued a relevant notice. The new version of the drug directory by the case, Western medicine, proprietary Chinese medicine and Chinese medicine Pieces 4 parts, of which Western medicine and proprietary Chinese medicine part of the total received 2535 drugs, compared with the 2009 version of the directory increased by 339, an increase of about 15.4%. Among them, the western medicine part of 1297, part of the 1238 Chinese medicine (including 88 kinds of national medicine), Chinese medicine Pieces not adjusted. The provinces (autonomous regions and municipalities) should carry out the new drug catalog by August 31 this year. The unified area shall carry out the new drug catalog within one month after the publication of the basic medical insurance, work injury insurance and maternity insurance medicines in the province (district and city), and update the list of hospital preparations included in the scope of fund payment according to the relevant regulations.
   People's Department of Social Affairs pointed out in the notice, insured personnel use the directory of Western medicine, proprietary Chinese medicines and Chinese herbal medicine Pieces of the costs incurred, according to the basic medical insurance, industrial injury insurance, maternity insurance to pay the relevant provisions. National free anti-HIV drugs and national public health programs related to anti-tuberculosis drugs, antimalarial drugs and anti-schistosomiasis drugs, insured personnel and use in public health payments, basic medical insurance, work injury insurance and maternity insurance fund Not to pay.
   In the release of the new version of the drug directory at the same time, the Ministry of Social Sciences confirmed that through expert review simultaneously identified 45 to be negotiated drugs, are higher clinical value but the price is relatively expensive patents, exclusive drugs. The next step will confirm whether the company has the intention to negotiate, to the public to announce the list of drugs to be negotiated and in accordance with the relevant rules to negotiate, meet the conditions of drugs included in the scope of medical insurance, the list released separately.
   The Ministry of Social Affairs, the provinces (autonomous regions and municipalities) social insurance authorities on the new version of the drug directory of Class A drugs shall not be adjusted, and should be in strict accordance with the existing laws and regulations and documents to adjust the B drugs. The new version of the drug directory adjustment to adhere to the expert review mechanism, adhere to fair, just and open, and do a good job of clean government risk prevention and control, not any name to the enterprise fees, shall not take any form of local protectionist behavior, administrative departments shall not interfere with experts Assessment results.
   With regard to the adjustment of Class B drugs and the requirements of the Ministry of Social Affairs, the provinces (autonomous regions and municipalities) should publish local basic medical insurance, industrial injury insurance and maternity insurance medicines by July 31, 2017. The number of adjustments (including transfers, transfers, adjustments to the limited range of payments) shall not exceed 15% of the number of national B drugs. The provinces (autonomous regions and municipalities) B drugs should be adjusted according to the provisions of the newspaper for the record.
   People's social requirements, the co-ordinate areas according to the area of medical institutions and retail pharmacies use of drugs, do a good job within the directory of drugs corresponding work, timely update and improve the information system drug database. The provinces (autonomous regions and municipalities) should establish a unified drug database of the province (district and city) to realize the unified management of the western medicine, Chinese medicine, hospital preparation and traditional Chinese medicine Pieces in the province. Focus on monitoring the amount of large, cost and more likely to exist unreasonable use of drugs, monitoring results in an appropriate manner to the public. Play pharmacist role, encourage medical institutions to take effective measures to promote clinical rational drug use.


【Disclaimer】

This article is reproduced, only for the exchange, does not mean that the views of this site, the site is not responsible for the authenticity of the content, hereby declare. If you are interested in the contents of the work, copyright and other issues, please contact us in the 30 days, we will be the first time to remove or replace the relevant content, but not related to the commitment to compensation. This article copyright and content interpretation of the original author of all.